The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 24,501–24,600 of 31,469
Eshriqui, I., Folchetti, L. D., Valente, A., de Almeida-Pititto, B., & Ferreira, S. R. G. (2019) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0516-8 · Cited by 5
Poor glucose regulation is associated with declines in well-being among older men, but not women.
Mantantzis, K., Drewelies, J., Düzel, S., Buchmann, N., Steinhagen‐Thiessen, E., Wagner, G. G., Raz, N., Lindenberger, U., Demuth, I., & Gerstorf, D. (2019) · Psychology and Aging · doi:10.1037/pag0000404 · Cited by 6
Krzesiński, P., Piechota, W., Piotrowicz, K., Gielerak, G. G., & Woźniak-Kosek, A. (2019) · Cardiology Research and Practice · doi:10.1155/2019/8571795 · Cited by 5
Lee, J., Lee, H. S., & Lee, Y. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.12.005 · Cited by 5
Santhi, T., & Mahendran, K. B. (2020) · International Journal of Clinical Biochemistry and Research · doi:10.18231/j.ijcbr.2020.012 · Cited by 5
Shiba, C. K., Dâmaso, A. R., Rhein, S. O., Machado, P. P., Masquio, D. C. L., Oyama, L. M., Lombardi, J. A. B., Duca, L. L., Tock, L., Oliveira, G. I., et al. (2020) · Nutrición Hospitalaria · doi:10.20960/nh.02777 · Cited by 5
Increased angiotensin II from adipose tissue modulates myocardial collagen I and III in obese rats
da Silva, D. C. T., Vileigas, D. F., Mota, G. A. F., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117650 · Cited by 5
Wang, Q., Wang, X., Liu, X., et al. (2018) · PubMed · doi:10.7499/j.issn.1008-8830.2018.08.004 · Cited by 5
Pathogenesis of Insulin Resistance
Zaman, G. S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.92864 · Cited by 6
Ohashi, K., Ohta, Y., Ishikawa, H., & Kitagawa, A. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-48 · Cited by 5
Diabetes and insulin resistance
Bell, K. J., Colagiuri, S., & Brand-Miller, J. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818460-8.00020-4 · Cited by 6
Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease
Małecki, P., Figlerowicz, M., Kemnitz, P., Mazur‐Melewska, K., Służewski, W., & Mania, A. (2020) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2020.99515 · Cited by 5
Cho, A., Lee, J., Lee, H. S., et al. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.11.010 · Cited by 5
Sajjadi, S. F., Mirzababaei, A., Abdollahi, A., Shiraseb, F., & Mirzaei, K. (2021) · BMC Research Notes · doi:10.1186/s13104-021-05582-z · Cited by 5
Estudo da Reatividade Microvascular em Pacientes Hipertensos com Adiposidade Corporal Elevada
d’El-Rei, J., Cunha, M. R., Mattos, S. S., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190364 · Cited by 5
Circulating Plasma Free Fatty Acids, Insulin Resistance and Metabolic Markers in Obese Women
Zaki, M. E., Hussein, J., Ibrahim, A. M. M., & Youness, E. R. (2020) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2034 · Cited by 5
Anti-obesity Effect of the Flavonoid Rich Fraction from Mulberry Leaf Extract
Go, E. J., Ryu, B. R., Yang, S. J., et al. (2020) · Korean Journal of Medicinal Crop Science · doi:10.7783/kjmcs.2020.28.6.395 · Cited by 5
Jao, J. K., Jacobson, D. L., Russell, J. S., Wang, J., Yu, W., Gojanovich, G. S., Siminski, S., Hyzy, L., Geffner, M. E., & Gerschenson, M. (2021) · AIDS · doi:10.1097/qad.0000000000002884 · Cited by 5
Psoinos, R. B. C., Morris, E. A., McBride, C. A., & Bernstein, I. M. (2021) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.07.246 · Cited by 7
Hsu, W., Tseng, C.-W., Huang, Y.-T., Liang, C., Lee, M., & Chen, S. (2021) · Healthcare · doi:10.3390/healthcare9081010 · Cited by 5
Yosef, T. M., Ibrahim, W. A., ElGhandour, A. M., et al. (2021) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-021-00075-8 · Cited by 5
Alencar, M. A. V. S. D., de Araújo, I. M., Parreiras‐e‐Silva, L. T., Nogueira‐Barbosa, M. H., Salgado, W., Elías, J., Salmón, C. E. G., & de Paula, F. J. A. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2021e11499 · Cited by 5
Gluvic, Z. M., Tomašević, R., Bojović, K., Obradovic, M. M., & Isenović, E. R. (2021) · Emergency and Critical Care Medicine · doi:10.1097/ec9.0000000000000016 · Cited by 5
Wang, D., Feng, D., Wang, Y., Dong, P., Wang, Y., Zhong, L., Li, B., Fu, J., Xiao, X., Speakman, J. R., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.788549 · Cited by 5
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., Lam, M. L., & Chaiken, R. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_34-2 · Cited by 5
Li, H., Xiao, P., Cheng, H., Zhao, X., Yan, Y., Liu, J., Xie, X., & Mi, J. (2022) · Nutrition · doi:10.1016/j.nut.2022.111651 · Cited by 5
Ye, C., Wang, Y., Kong, L., Zhao, Z., Li, M., Xu, Y., Xu, M., Lu, J., Wang, S., Lin, H., et al. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13289 · Cited by 4
Effect of Adding Exercise to a Diet Containing Glucomannan
Vingren, J. L., Silvestre, R., Hatfield, D. L., Spiering, B. A., Fragala, M. S., Ho, J., Maresh, C. M., Volek, J. S., DeFreitas, J. M., Puglisi, M. J., et al. (2007) · The FASEB Journal · doi:10.1096/fasebj.21.5.a578-d · Cited by 5
Gender and Racial/Ethnic Differences
Paulus, P. (1988) · Research in criminology · doi:10.1007/978-1-4612-3812-6_7 · Cited by 18
Blé‐Castillo, J. L., Aparicio-Trápala, M. A., Gómez-Vázquez, A., et al. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 5
Diabetes Mellitus and Magnesium
Emoto, M., & Nishizawà, Y. (2007) · Springer eBooks · doi:10.1007/978-1-84628-483-0_16 · Cited by 5
Soluble CD40 Ligand Levels in Otherwise Healthy Subjects With Impaired Fasting Glucose
Taşçı, İ., Doğru, T., Sönmez, A., Genç, H., Kılıç, S., Olgun, A., Gök, M., Erdem, G., & Erikçi, S. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/32508 · Cited by 5
Cenci, M. C. P., Soares, D. V., Spina, L. D. C., Brasil, R. R. L. O., Lobo, P. M., Micmacher, E., Vaisman, M., Boguszewski, C. L., & Conceição, F. L. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.04.002 · Cited by 5
Strufaldi, M. W. L., Puccini, R. F., Amâncio, O. M. S., & Franco, M. D. C. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1846-x · Cited by 5
Xia, R., Huang, P. C., & Shao, G.-M. (2006) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nel088 · Cited by 5
Nonfasting Lipemia and Inflammation as Cardiovascular Disease Risks After SCI
Nash, M. S., & Mendez, A. J. (2009) · Topics in Spinal Cord Injury Rehabilitation · doi:10.1310/sci1403-15 · Cited by 5
Ueno, N., & Satoh, Y. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2008.01.001 · Cited by 5
Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy
Ross, A. C., Hileman, C. O., Brown, T. T., Fedarko, N. S., Storer, N. J., Labbato, D. E., & McComsey, G. A. (2012) · HIV Clinical Trials · doi:10.1310/hct1304-212 · Cited by 5
Rosa, F., Romero-Vecchione, E., Vasquez, J. J., Antequera, R., & Strauss, M. (2007) · Revista Española de Cardiología · doi:10.1157/13109648 · Cited by 5
Tentolouris, N., Papazafiropoulou, A. K., Liatis, S., Moyssakis, I. E., Perrea, D. N., Soldatos, R. F., & Katsilambros, N. L. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.09.004 · Cited by 5
Decreased erythrocyte insulin binding in hypertensive subjects with hyperinsulinemia
Corry, D. B., Joolhar, F., Hori, M., & Tuck, M. L. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02336-6 · Cited by 5
Okahashi, A., Okada, T., Saito, E., Miyashita, M., Kuromori, Y., Iwata, F., Hara, M., Mugishima, H., Kitamura, Y., & Shimizu, T. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.12.013 · Cited by 5
Völkl, T. M. K., Rauh, M., Schöfl, C., & Dörr, H. G. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.05.001 · Cited by 5
de Luis, D. A., Ballesteros-Pomar, M. D., Ruiz, E., Cordero, M., Muñoz, C., Penacho, M. A., Iglesias, P., Guzman, A. L., Maldonado, A., Martín, L. S., et al. (2010) · Annals of Nutrition and Metabolism · doi:10.1159/000321632 · Cited by 5
Hedman, M., Rolandsson, O., Hägg, E., et al. (2003) · Autoimmunity · doi:10.1080/08916930310001607943 · Cited by 5
Ayyappa, K. A., Ghosh, S., Mohan, V., & Radha, V. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0302 · Cited by 5
Player, M. S., Mainous, A. G., King, D. E., Díaz, V. A., & Everett, C. J. (2009) · Nutrition · doi:10.1016/j.nut.2009.03.006 · Cited by 5
Kim, J., & Kim, E. (2012) · 대한지역사회영양학회지 · doi:10.5720/kjcn.2012.17.5.530 · Cited by 5
Diabetes mellitus tipo 2: fatores preditivos na população nipo-brasileira
do Nascimento, R., Franco, L. J., Gimeno, S. G. A., Hirai, A. T., & Ferreira, S. R. G. (2003) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302003000500013 · Cited by 5
Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations
North, K. E., Franceschini, N., Avery, C. L., Baird, L. M., Graff, M., Leppert, M., Chung, J. H., Zhang, J., Hanis, C. L., Boerwinkle, E., et al. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0162-z · Cited by 5
Martínez‐Abundis, E., González-Ortı́z, M., & Grover‐Páez, F. (2001) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00144-6 · Cited by 5
Murase, Y., Yagi, K., Kobayashi, J., et al. (2005) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.11.033 · Cited by 5
The role of TNF-α G-308A promoter polymorphism in glycemic control in Type 2 diabetes patients
Al-Azzam, S. I., Khabour, O. F., Alzoubi, K. H., Ghanma, M. W., & Alhasan, A. Y. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-013-0002-4 · Cited by 5
Morales, L. M., Raleigh, X., Fernández, V., & Molero-Conejo, E. (2007) · Revista médica de Chile · doi:10.4067/s0034-98872007000200009 · Cited by 5
β-3AR W64R Polymorphism and 30-Minute Post-Challenge Plasma Glucose Levels in Obese Children
Verdi, H., Kınık, S. T., Yalçın, Y., Şahin, N. M., Yazıcı, A. C., & Ataç, F. B. (2015) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.1629 · Cited by 5
Sartoretto, J. L., Santos, R. A. S., Scavone, C., et al. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.8.0009 · Cited by 5
Li, C., Tsai, S., & Chou, P. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.11.023 · Cited by 5
Matsumoto, N., Arase, Y., Kawamura, Y., Ohmoto-Sekine, M., Amakawa, K., Ogawa, K., Tsuji, H., Dong, H. S., Hara, S., Akuta, N., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3437 · Cited by 5
Sayyad, M. G., Gopal, G., & Shahani, A. K. (2011) · Journal of Applied Sciences · doi:10.3923/jas.2011.2076.2083 · Cited by 5
Cordeiro, A. C., Carrero, J. J., Barany, P. F., Qureshi, A. R., Heimbürger, O., Lindholm, B., & Stenvinkel, P. (2010) · American Journal of Nephrology · doi:10.1159/000322608 · Cited by 5
Harvie, M., Renehan, A. G., Frystyk, J., Flyvbjerg, A., Mercer, T., Malik, R., Adams, J. E., Cuzick, J. M., & Howell, A. (2010) · The Open Obesity Journal · doi:10.2174/1876823701002020063 · Cited by 5
McMillen, T. S., Minami, E., & LeBoeuf, R. C. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.19 · Cited by 5
Aksnes, T. A., Flaa, A., Sevre, K., Mundal, H. H., Rostrup, M., & Kjeldsen, S. E. (2008) · Blood Pressure · doi:10.1080/08037050802162847 · Cited by 5
Kabaroğlu, C., Ersoy, B., Onur, E., Özhan, B., Erdin, S., Var, A., Bayındır, O., & Dinç, G. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0079 · Cited by 5
Obesity Defined by Body Mass Index and Metabolic Status in the Elderly
Choi, J. (2011) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2011.15.4.222 · Cited by 5
Early postprandial Insulin secretion: Its relation to Insulin sensitivity
Kabadi, U. M., & Kabadi, M. U. (2011) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2011.11001 · Cited by 5
García-Díaz, J. D. D., de Guzmán, A. L., Monzó, L. S., et al. (2008) · Medicina Clínica · doi:10.1157/13116327 · Cited by 5
Ko, G. T. C., Cockram, C. S., Critchley, J., Lau, M. S., & Chan, J. C. N. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1045 · Cited by 5
Visnegarwala, F., Darcourt, J. G., Sajja, P., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308150-00018 · Cited by 5
Ruchat, S.-M., Girard, M., Weisnagel, S. J., et al. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04972.x · Cited by 5
Brasil, R. R. L. O., Soares, D. V., Spina, L. D. C., Lobo, P. M., da Silva, E. M. C., Mansur, V. A., Pinheiro, M. F. M. C., Conceição, F. L., & Vaisman, M. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346297 · Cited by 5
Ghanem (2010) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2010.195.203 · Cited by 5
Duvillard, L., Florentin, E., Pont, F., Petit, J., Baillot-Rudoni, S., Penfornis, A., & Vergès, B. L. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301597 · Cited by 5
Holzapfel, C., Klopp, N., Grallert, H., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0297 · Cited by 5
Pilaczyńska-Szczȩśniak, Ł., Lisiecki, D., Kasprzak, Z., Karolkiewicz, J., Śliwicka, E., Nowak, A., Podgórski, T., & Lewandowska, M. (2011) · Journal of Human Kinetics · doi:10.2478/v10078-011-0007-z · Cited by 5
Metabolic characteristics of breakfast-vegetarian (BV) elderly people in rural Taiwan
Juang, S.-J., Peng, L., Lin, M.-H., Lai, H., Hwang, S., Chen, L., & Chiou, S.-T. (2009) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2009.01.004 · Cited by 5
Lai, Y.-C., Li, H., Wu, T.-J., Jeng, C.-Y., & Chuang, L. (2014) · PPAR Research · doi:10.1155/2014/917823 · Cited by 5
García-Larsen, V., Bustos, P., Amigo, H., Potts, J., & Rona, R. J. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-206 · Cited by 5
Torres, M. D., Tormo, M. A., Campillo, C., Carmona, M., Torres, M., Reymundo, M. G., García, P., & Campillo, J. E. (2008) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(08)60252-2 · Cited by 5
Ybarra, J., Planas, F., & Pou, J. M. (2008) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2008.004 · Cited by 5
Metabolic Syndrome Is a Risk Factor for the Development of Chronic Renal Disease
Kebapçı, N., Uslu, S., & Özçelik, E. Y. (2013) · Renal Failure · doi:10.3109/0886022x.2013.774680 · Cited by 5
Ohkawa, H., Fukuwa, C., Nagata, N., Yokogawa, K., Omura, K., & Miyamoto, K. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.4.0008 · Cited by 5
The relation between leptin and insulin remains when insulin secretion is disturbed
Jazet, I. M., Fogteloo, A. J., & Meinders, A. E. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.11.003 · Cited by 5
Abbasi, F., Lamendola, C. A., & Reaven, G. M. (2010) · Metabolism · doi:10.1016/j.metabol.2010.02.015 · Cited by 5
Chen, J.-S., Wu, C., Chu, N., Chang, L.-C., Pei, D., & Lin, Y. (2015) · International Journal of Endocrinology · doi:10.1155/2015/170987 · Cited by 5
Assessment of Insulin Resistance and Its Clinical Application
Kim, J.-H., Lee, L. Y., & Lee, S. (2009) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2009.24.2.75 · Cited by 5
Abenavoli, L., Peta, V., & Milić, N. (2015) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30809-9 · Cited by 5
García‐Broncano, P., Berenguer, J., Fernández‐Rodríguez, A., Tenor, D. P., Jiménez‐Sousa, M. Á., García–Álvarez, M., Miralles, P., Aldámiz‐Echevarría, T., López, J. C., Micheloud, D., et al. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0235-9 · Cited by 5
Leptin Response to Oral Glucose Tolerance Test in Obese and Nonobese Premenopausal Women
Çakır, M., Sarı, R., Tosun, Ö., & Karayalçın, Ü. (2005) · Endocrine Research · doi:10.1080/07435800500228500 · Cited by 5
akagami, T. N., & Yamamoto, Y. (2011) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000140 · Cited by 5
Komatsu, T., Komatsu, S., Nakamura, H., Kuroyanagi, T., Fujikake, A., Hisauchi, I., Sakuma, M., Nakahara, S., Sakai, Y., & Taguchi, I. (2016) · Circulation Journal · doi:10.1253/circj.cj-15-1012 · Cited by 5
Pubertal Progression and Serum Lipid Profile in Obese Children
Güven, A., & Sanisoğlu, S. Y. (2008) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2008.21.2.135 · Cited by 5
강설중, & Kim, B.-R. (2009) · Exercise Science · doi:10.15857/ksep.2009.18.4.443 · Cited by 5
Mostafa, A. M., Mohamed, W. S., & Serwah, A. H. A. (2014) · The Egyptian Journal of Hospital Medicine · doi:10.12816/0002438 · Cited by 5
Kim, H.-J., Sung, S., & Lee, M.-G. (2010) · Exercise Science · doi:10.15857/ksep.2010.19.3.321 · Cited by 5
Esteghamati, A., Sheikhbahaei, S., Hafezi‐Nejad, N., et al. (2014) · PubMed · Cited by 5
Hyperinsulinemia and waist circumference in childhood metabolic syndrome.
Lone, S. W., Atta, I., Ibrahim, M. N., et al. (2011) · PubMed · Cited by 5
A new perspective in diagnosing polycystic ovary syndrome.
Ertörer, M. E., Anaforoğlu, İ., Bozkırlı, E., Bakıner, O., Tütüncü, N. B., & Demirağ, N. G. (2007) · PubMed Central · Cited by 5
Wu, C., Pei, D., Su, C., Hsiao, F., Chu, Y., Lee, L.-H., Wang, K., Hsieh, A., Lin, J.-D., & Hsia, T. (2010) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v39n1p4 · Cited by 5
Fairey, A., Courneya, K. S., Field, C. J., Bell, G. J., Jones, L. W., & Mackey, J. R. (2003) · PubMed · Cited by 221
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
